BenevolentAI

In News

BenevolentAI Limited Announces Appointment of Kenneth Patrick Mulvany as Director, Effective March 10, 2026 - marketscreener.com

marketscreener.com - Mar 18, 2026

The AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology’s limits - Fortune

Fortune - Sep 12, 2025

AI Drug Discovery Market Is Going to Boom | Major Giants Insilico Medicine, BenevolentAI, Exscientia, Atomwise - openPR.com

openPR.com - Mar 05, 2026

BenevolentAI Unveils Major Strategic Overhaul With Return to Original Mission - Business Wire

Business Wire - Dec 11, 2024

Britain in danger of outsourcing its intellect, warns AI pioneer - The Telegraph

The Telegraph - Dec 14, 2025

Merck KGaA links with BenevolentAI and Exscientia to expand AI capabilities - Pharmaceutical Technology

Pharmaceutical Technology - Sep 20, 2023

BenevolentAI: using artificial intelligence to speed up drug discovery - finance.yahoo.com

finance.yahoo.com - Oct 06, 2024

BenevolentAI, cruel R&D: AI-enabled drug flunks midphase eczema trial to dent deal plans - Fierce Biotech

Fierce Biotech - Apr 05, 2023

BenevolentAI exploring novel AI-driven drug discovery methods - drugdiscoverytrends.com

drugdiscoverytrends.com - May 03, 2023

AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio Roots - MedCity News

MedCity News - Dec 11, 2024

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease - The Lancet

The Lancet - Feb 04, 2020

Co-founders Mulvaney, Brennan return to BenevolentAI as CEO Moeller departs - BioCentury

BioCentury - Oct 18, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment